☎ (888) 264-7050
Formaldehyde at 0.5 ppm: The Action Level That Starts a 6-Month Monitoring Cycle

Formaldehyde at 0.5 ppm: The Action Level That Starts a 6-Month Monitoring Cycle

Formaldehyde at 0.6 ppm is under the 0.75 ppm PEL and still over the action level, which starts 6-month monitoring and medical surveillance under 1910.1048.

The result comes back at 0.6 ppm. The lab report prints the OSHA permissible exposure limit for formaldehyde at 0.75 ppm next to it, so the number reads clean. The EHS manager initials the report and it goes in the exposure file. That filing is where the facility picks up its problem, because formaldehyde has a third number sitting below the PEL, the action level at 0.5 ppm, and 0.6 ppm cleared it. From the day that sample was taken, the plant owed periodic exposure monitoring every 6 months and a medical surveillance program for every employee in that job assignment.

Nothing about operating at 0.6 ppm is unlawful. The citation risk lives entirely in the two ongoing programs the number starts, and in the fact that most facilities have never set either one up. Below is what 29 CFR 1910.1048 actually requires once a result lands at or above 0.5 ppm, what it does not require, and the two places where the agency’s own paperwork will steer a careful reader wrong.

What is the OSHA formaldehyde action level?

The action level is 0.5 parts per million of formaldehyde as an 8-hour time-weighted average, defined at 29 CFR 1910.1048(b). It is not an exposure limit. The enforceable limits are the 0.75 ppm 8-hour TWA PEL and the 2 ppm 15-minute short-term exposure limit at 1910.1048(c)(1) and (c)(2). The action level is the trigger point for ongoing monitoring and medical surveillance.

That split is the whole design of the standard. Paragraph (c) tells you the ceiling you may not cross. Paragraph (b) sets a lower number whose only function is to switch on programs. An industrial hygiene report that evaluates a result against the PEL alone answers half the question the standard asks.

The standard reaches all occupational exposures to formaldehyde, whether the source is formaldehyde gas, a solution such as formalin, or a material that releases formaldehyde as it is heated, cured, sprayed or sanded (1910.1048(a)). The text in force today comes from the 1992 amendment recorded in the section’s own source credit at 57 FR 22310, May 27, 1992, which set the 0.75 ppm PEL. Any document that states 1.0 ppm predates that amendment.

What does a formaldehyde result at or above 0.5 ppm actually trigger?

Two programs start. Periodic exposure monitoring at least every 6 months under 1910.1048(d)(3)(ii), and a medical surveillance program for every employee exposed at or above the action level under 1910.1048(l)(1)(i), including the medical disease questionnaire before job assignment and annually after. Neither obligation depends on exceeding the 0.75 ppm PEL.

Around those two, the standard adds obligations that are easy to overlook because they look administrative. Each affected employee has to be notified of the monitoring results, in writing or by posting, within 15 working days of the employer receiving them (1910.1048(d)(6)). The physician performing any required examination has to be given the standard plus appendices A, C, D and E, a description of the employee’s duties, the representative exposure level for the job assignment, and the respirator and PPE information (1910.1048(l)(6)). A written physician opinion comes back for every required examination and goes in the employee’s medical record (1910.1048(l)(7) and (o)(3)(ii)).

Then the records sit for a long time. Exposure records run at least 30 years, and medical records run for the duration of employment plus 30 years (1910.1048(o)(5)). Objective data used in place of monitoring is itself a record that has to be kept under (o)(2), which is the quiet trap in paragraph (d): an employer who decided years ago that exposures were low and never wrote the determination down has no defense on file.

Does a formaldehyde action-level result require a regulated area?

No. Regulated areas are required only where the airborne concentration exceeds either the TWA PEL or the STEL, under 1910.1048(e)(1)(i). A facility sitting at 0.6 ppm owes 6-month monitoring and medical surveillance but no regulated area, no access restriction and no DANGER FORMALDEHYDE signage at the entrances.

This cuts both ways, and the overbuilt version costs real money. Facilities that read an action-level result as a regulated-area trigger put up signage, restrict entry and start issuing respirators to a population the standard never asked them to enroll. Meanwhile the medical questionnaire, which is what the result actually required, never goes out. Respirators come into play only where feasible engineering and work practice controls cannot bring exposure to or below the TWA and the STEL (1910.1048(f)(1) and (f)(2)), and controls are the first obligation, not the respirator.

Who this standard reaches, and the check you can run this afternoon

OSHA’s own paperwork estimate puts the covered population at 80,905 employers and 1,953,732 workers, and that count went up by 95,368 workers in the February 2026 information collection renewal (91 FR 9656, OMB control number 1218-0145). In iSi’s region the covered operations are concentrated in histology, pathology and anatomy laboratories at hospitals and reference labs; mortuaries and embalming rooms; particleboard, MDF and plywood plants; foundries running phenol-formaldehyde or urea-formaldehyde core binders; fiberglass and mineral wool insulation lines; textile finishing and permanent-press operations; and resin and adhesive compounding.

Three steps settle whether you are in scope, and none of them requires a consultant.

  1. Pull the safety data sheet for every product in the process and read Section 3 for formaldehyde, formalin, paraformaldehyde, urea-formaldehyde, phenol-formaldehyde or melamine-formaldehyde, with the concentration.
  2. If any product is above 0.1 percent formaldehyde, or the process heats, cures, sprays or sands a formaldehyde resin, the standard is in play and you need either air monitoring or a documented objective-data determination under 1910.1048(d)(1)(ii).
  3. If there is no monitoring record and no written objective-data determination in the file, paragraph (d) is open. The determination itself is a required record under (o)(2), so an undocumented judgment call is the same as nothing.

One distinction keeps panel plants chasing the wrong number. EPA’s formaldehyde emission standards for composite wood products under TSCA Title VI set product emission limits of 0.05 ppm for hardwood plywood, 0.09 ppm for particleboard, 0.11 ppm for medium-density fiberboard and 0.13 ppm for thin MDF, tested by ASTM E1333-14 (40 CFR 770.10, 81 FR 89724). Those figures describe what a finished panel may emit inside a test chamber. They say nothing about what a worker breathes. A plant in full compliance with 40 CFR Part 770 can still be over the OSHA action level at the press or the sander, and the two programs share no data.

How often must formaldehyde monitoring be repeated after an action-level result?

At least every 6 months for employees shown by monitoring to be at or above the action level, per 1910.1048(d)(3)(ii). If a result was at or above the 2 ppm STEL, add STEL monitoring at least once a year under worst conditions, per (d)(3)(iii). A process, equipment, personnel or control change restarts initial monitoring under (d)(2)(ii).

The clock runs off your own last result, which makes this cadence easy to lose track of. There is no Federal Register date that tells a facility when its next formaldehyde sample is due. The due date is 6 months from the last sampling period, and it keeps rolling until the termination test in paragraph (d)(4) is satisfied. Two other events reset the sequence. A change in production, equipment, process, personnel or control measures that may result in new or additional exposure sends you back to initial monitoring under (d)(2)(ii), and a report of respiratory or dermal signs or symptoms obliges prompt monitoring of the affected employee under (d)(2)(iii).

The accuracy requirement shifts with the number you are measuring against, which matters when you pick a method. Monitoring has to be accurate to within plus or minus 25 percent at a 95 percent confidence level for the TWA and the STEL, and within plus or minus 35 percent at a 95 percent confidence level at the action level (1910.1048(d)(5)). Method and media selection is its own subject, covered in industrial hygiene sampling types and methods, and the question of how many samples a small facility needs before the result means anything is worked through in sampling iterations and Bayesian decision analysis.

When can periodic formaldehyde monitoring be discontinued?

Only when results from two consecutive sampling periods taken at least 7 days apart show exposure below both the action level and the STEL, under 1910.1048(d)(4). The results must be statistically representative and consistent with the employer’s knowledge of the job. One clean sample does not end the 6-month cycle.

Two conditions in that paragraph get skipped. The 7-day separation is a minimum, so two samples pulled on the same shift or on consecutive days do not qualify no matter how low they read. And both results have to be below the action level and below the STEL, which means a day with a short formalin pour that spikes a 15-minute sample above 2 ppm leaves you in the cycle even when the 8-hour average looks fine. Facilities that want out of the 6-month cadence get there faster by fixing the task that produces the peak than by sampling repeatedly around it.

How soon must employees be told their formaldehyde monitoring results?

Within 15 working days after the employer receives the results, individually in writing or posted in a location accessible to employees, per 1910.1048(d)(6). Where exposure is above the PEL, the notification must also describe the corrective action the employer is taking. The clock runs from receipt of results, not from the sampling date.

That detail decides whether a late notification is a paperwork lapse or a citation. Lab turnaround is not part of the employer’s 15 working days, so the received-date stamp on the analytical report is the document that proves the window. Facilities that route lab reports to a shared mailbox, or to a corporate address in another state, routinely burn a week of the window before anyone with a duty under the standard has seen the number. Date-stamp the report on arrival and the rest of the obligation is manageable.

The agency’s own enforcement directive is 36 years old and still prints the wrong PEL

OSHA’s enforcement directive for this standard is CPL 02-02-052, Enforcement Procedure for Occupational Exposure to Formaldehyde, issued November 20, 1990 with CH-1 page changes of October 7, 1991. It is still the active directive, and it is useful: it tells compliance officers to verify exposure with bulk or air samples, directs that exposure determinations rest on actual measurements unless the employer holds objective data, requires monitoring to be repeated on production, equipment, process, personnel or control changes, and routes citations by paragraph, with general PPE under (h), specified PPE under (h)(1), training under (n) rather than the Hazard Communication training provisions, and emergency provisions under (k) grouped with any applicable 1910.120 violations.

It was also never conformed to the 1992 amendment. The directive still presents 1.0 ppm as the PEL and describes 0.75 ppm as a proposal that cannot be enforced until final. It cites 1910.1048(d)(1)(ii)(A), a paragraph that does not exist in the codified text, where the objective-data exception sits at (d)(1)(ii) with no subparagraph. An employer or a consultant who builds a formaldehyde program from the directive alone is working from a limit that was superseded 34 years ago, and is off by a third on the only number most programs track.

The practical rule: use the directive for enforcement procedure and citation routing, and use the current eCFR text of 1910.1048 for every number. Where the two disagree on a figure, the CFR text wins and the directive is the stale document. The same check is worth running on any third-party program document that cites a formaldehyde PEL without a date.

Does the laboratory standard or the formaldehyde standard cover a histology or pathology lab?

The formaldehyde standard. OSHA Instruction CPL 02-02-052, Section 9.1(2), states that the Laboratory standard at 29 CFR 1910.1450 does not cover formaldehyde use in histology, pathology, and human or animal anatomy laboratories. Those labs run the full 1910.1048 apparatus. A Chemical Hygiene Plan does not substitute for it.

This is the single most expensive misread in the standard, and it is concentrated in exactly the facilities that handle the most formalin. A hospital histology lab builds a Chemical Hygiene Plan, appoints a Chemical Hygiene Officer, trains to it annually and treats formaldehyde as one chemical inside that program. Every piece of that is reasonable laboratory practice and none of it answers 1910.1048. The lab still owes exposure monitoring, the 6-month cadence once a result lands at or above 0.5 ppm, the 15-working-day notification, the medical disease questionnaire before assignment and annually, and the 30-year exposure records.

Grossing stations are where the numbers come from. Specimen pours, bucket decanting and container top-off are short, high-concentration tasks, which is why a lab can show an unremarkable 8-hour average and a 15-minute sample over 2 ppm on the same day. If your facility’s formaldehyde posture is currently a line item in a Chemical Hygiene Plan, the scope of that plan is too narrow for what 1910.1048 asks. What a Chemical Hygiene Plan has to contain, and who it does cover, is laid out in OSHA Chemical Hygiene Plan requirements for laboratories.

What does a research laboratory owe when the formaldehyde action level is routinely exceeded?

For laboratories that do fall under 1910.1450, routinely exceeding the action level pulls in two paragraphs by operation of 1910.1450(a)(2)(iii). Under 1450(d)(2) the employer must immediately comply with the exposure monitoring provisions of 1910.1048, and under 1450(g)(1)(ii) medical surveillance must be established as prescribed by that standard.

So the Laboratory standard does not insulate a research lab from the formaldehyde monitoring and medical provisions. It routes to them. A university or corporate research lab that runs formalin fixation at bench scale and keeps clearing 0.5 ppm is in the same monitoring and medical posture as a production facility, with the Chemical Hygiene Plan still governing everything else it does with chemicals. The two standards operate together in that case rather than in the alternative, which is covered in more detail in the Chemical Hygiene Plan post.

Is the 0.1 ppm formaldehyde training exemption the same as the action level?

No. Two different numbers doing two different jobs. Objective data showing no exposure at or above 0.1 ppm removes the annual training requirement under 1910.1048(n)(1). The 0.5 ppm action level governs monitoring frequency and medical surveillance. NIOSH separately publishes a 0.1 ppm 15-minute ceiling, which is a recommendation and not an OSHA trigger.

Three numbers below the PEL get mixed up with each other in practice, and only one of them is the action level.

NumberWhat it isWhat it does
0.1 percentA concentration in the product, read off SDS Section 3Below this, CPL 02-02-052 Section 9.3(3) tells compliance officers not to cite a failure to monitor where exposure also stays below 0.1 ppm and there are no employee health complaints
0.1 ppm in airAn airborne concentration, demonstrated with objective dataBelow this, the annual training obligation under 1910.1048(n)(1) does not apply
0.5 ppm in airThe action level at 1910.1048(b)At or above this, 6-month periodic monitoring under (d)(3)(ii) and medical surveillance under (l)(1)(i) both start

The 0.1 ppm figure is the one most often mistaken for a safe harbor. It relieves training and nothing else, and it only does that where the employer holds objective data to support it. Once a sample comes back at or above 0.5 ppm, neither 0.1 ppm threshold relieves anything. The pattern is the same one that shows up in the other substance-specific health standards, where a number below the PEL carries the program weight: see the hexavalent chromium exposure limits post and the creosote exposure limits post for how the same architecture plays out on other substances.

What medical surveillance does a formaldehyde action-level result require, and what does it cost?

A medical surveillance program under 1910.1048(l)(1)(i): a medical disease questionnaire before assignment and annually after under (l)(3), a physician-directed examination where the questionnaire indicates one under (l)(4), and a written physician opinion under (l)(7), all at no cost to the employee. OSHA’s own 2026 paperwork estimate prices a covered exam at $269.48 and a contract industrial hygiene sample at $60.64.

The no-cost provision is broader than the invoice. Examinations and questionnaires have to be provided without cost to the employee, without loss of pay, and at a reasonable time and place (1910.1048(l)(2)). An employer who schedules the annual questionnaire on an employee’s day off and does not pay for the time has an open (l)(2) issue separate from whether the surveillance happened.

What the program costs when you run OSHA’s own figures

Those two unit costs come from the February 2026 information collection renewal at 91 FR 9656, and they are the numbers OSHA uses on itself, which makes them hard to argue with in a budget meeting. Across the covered population the agency puts the annual burden at 277,695 hours and $59,913,352, up from $54,153,624 in the prior estimate. The per-unit figures rose the same way: $269.48 per medical exam against $259.12 before, and $60.64 per contract industrial hygiene sample against $55.99.

Scale that to a single facility. Take a histology lab with 6 employees above the action level. Two sampling rounds a year at 6 personal samples each is 12 samples, or $727.68 at OSHA’s contract rate. Six covered medical exams at $269.48 is $1,616.88. The annual program runs about $2,344.56 in direct cost before any internal time. One serious violation for not running it carries up to $16,550, which is roughly seven years of the program in a single citation.

What is the penalty for a formaldehyde monitoring or medical surveillance violation in 2026?

Up to $16,550 per serious violation and $165,514 per willful or repeat violation, with a willful minimum of $11,823 and $16,550 per day for failure to abate, under 29 CFR 1903.15(d). These figures are in effect for 2026 unchanged from 2025. OSHA’s memorandum of May 21, 2026 confirms no inflation-based increases were made this year, citing OMB Memorandum M-26-11 and the Bureau of Labor Statistics being unable to produce the October 2025 CPI-U.

Two things follow from flat penalties. The deterrent figure did not move, so a budget built on last year’s exposure numbers is still accurate. And the paragraph structure of this standard means a single gap rarely produces a single citation. A facility that filed a 0.6 ppm result and did nothing has an open (d)(3)(ii) monitoring item, an open (d)(6) notification item and an open (l)(1)(i) medical surveillance item, each of which is separately citable, with failure to abate running at $16,550 per day after that.

On how often those paragraphs are actually cited, this post says nothing, deliberately. The per-standard citation and penalty totals for 1910.1048 live in OSHA’s IMIS industry profile tool, which did not return data on the research run behind this post. No formaldehyde-specific enforcement case with a stated penalty amount was located in OSHA news releases for 2024 through 2026 either. Treat any ranking of frequently cited formaldehyde paragraphs you see elsewhere as unsourced until someone shows you the IMIS pull.

Do formaldehyde requirements differ in Kansas, Missouri, Oklahoma, Nebraska, Texas or Colorado?

No. None of the six has an OSHA-approved State Plan, so federal 29 CFR 1910.1048 applies directly to private-sector employers in all of them, per OSHA’s State Plans page. The one real gap is in the public sector: state and local government workers in those six states are not covered by federal OSHA, which leaves county hospital and public university labs outside this standard’s federal reach.

That gap is a jurisdictional hole, and it lands on the exact facilities that run the most formalin. A county hospital histology lab, a city mortuary service or a state university anatomy lab in any of the six sits outside federal OSHA jurisdiction for formaldehyde. Kansas handles the public sector through the Kansas Department of Labor Industrial Safety and Health Division, whose overview page describes a program serving both private and public sector organizations, with a Public Sector Safety Specialist conducting workplace inspections and working toward compliance with state and federal safety regulations including OSHA standards. That page cites no statutory authority and does not say whether the division can issue citations or assess penalties, so read it as an inspection and compliance-assistance route rather than an enforcement one. The arrangements in the other five states were not verified for this post and should not be assumed to match Kansas.

For a public-sector lab the practical answer is unchanged. The medical and legal exposure from an uncontrolled formaldehyde process does not depend on which agency has jurisdiction, and 1910.1048 is the only published program standard anyone is going to measure the lab against, whether or not a federal inspector can walk in.

There is a live proposal to trim this standard, and it does not touch any of this

A reader who follows rulemaking has heard that formaldehyde is on the table, and that is accurate. OSHA has an open proposal to revise this standard under RIN 1218-AD64, docket OSHA-2025-0026, proposed at 90 FR 28286 on July 1, 2025, with the comment period extended at 90 FR 40551 and the record reopened for 30 more days on July 22, 2026 after consultations with the Advisory Committee on Construction Safety and Health. Comments closed August 21, 2026. Formaldehyde also went to informal public hearings beginning August 19, 2026 alongside 16 other health standards.

Read the scope before you plan around it. The standard numbers listed on OSHA’s own Federal Register index entry for the July 1, 2025 proposal are 1910.1048, 1910.1048(g), 1910.1048(g)(1), 1910.134, 1910.134(a)(2), 1910 Subpart Z, 1915.1048, 1918.1, 1926.1148 and 1953.5(a). Paragraph (g) is respiratory protection. The proposal does not reach paragraph (b), where the action level lives, paragraph (c), where the PEL and STEL live, or paragraph (d), the monitoring paragraph. The relief on the table concerns respirator program requirements and their alignment with 1910.134. Everything described in this post survives it.

The signals pointing the other way are just as concrete. OSHA’s own covered-worker count went up by 95,368 in the February 2026 renewal, from 1,858,364 to 1,953,732, with estimated annual cost rising to $59,913,352. And the distance between the legal limit and the health-based recommendation has not changed: the NIOSH recommended exposure limit is 0.016 ppm as a TWA with a 0.1 ppm 15-minute ceiling, roughly 47 times below the OSHA PEL and 31 times below the action level, and NIOSH carries formaldehyde as a potential occupational carcinogen with an IDLH of 20 ppm. A facility at 0.6 ppm is lawfully compliant and nowhere near the recommended limit, which is the framing an insurer or a plaintiff’s expert will use years later.

What to do with a result that just came back at or above 0.5 ppm

  1. Date-stamp the analytical report on receipt. That date starts the 15 working days for employee notification under 1910.1048(d)(6), not the sampling date.
  2. Notify every affected employee in writing or by posting within that window, and add a description of corrective action if any result exceeded 0.75 ppm.
  3. Put the affected job assignments on a 6-month sampling calendar under (d)(3)(ii), and add annual worst-conditions STEL sampling if any 15-minute result reached 2 ppm.
  4. Issue the medical disease questionnaire to every employee at or above the action level, and set the annual recurrence under (l)(3). Send the physician the standard with appendices A, C, D and E, the duty description, the representative exposure level and the respirator information required by (l)(6).
  5. Write down the engineering and work practice controls you are evaluating under (f)(1), because a respirator-only answer is citable where feasible controls exist.
  6. File the exposure records for 30 years and the medical records for employment plus 30 years under (o)(5), and file any objective-data determination as the record (o)(2) requires.
  7. Check every program document that states a formaldehyde PEL. If it says 1.0 ppm, it predates the 1992 amendment and has to be corrected.

A facility that has just worked through that list usually finds the same two gaps: nobody owns the 6-month sampling calendar, and nobody owns the annual questionnaire. iSi’s industrial hygiene team runs the sampling rounds, handles the notification letters and the recordkeeping, and coordinates the medical surveillance so the physician gets what (l)(6) requires. For a plant or a lab with no one to carry a 6-month monitoring cycle and an annual medical program on top of the day job, the EHS cooperative program, or EHS COOP, puts an iSi project manager on the facility’s calendar to run those cycles as recurring tasks rather than annual fire drills. Call iSi at (316) 264-7050 or contact us with the result in hand and you will get a response the same day.

Sources